Skip to content
Amorepacific’s Q2 profit soars 148% on global derma push, but China sales slip

South Korean beauty giant Amorepacific posted Q2 2026 beauty revenue of 1.176 trillion won ($902 million), up 17% YoY, with net profit surging 148.1% to 93.4 billion won ($71.6 million). Gross margin improved to 73.60%, driven by overseas sales of high-margin functional skincare brands Cosrx, Aestura, and Illiyoon. The Americas surged 56.5% to 210.4 billion won ($161.4 million) and EMEA jumped 63.3%, while North Asia, including Greater China, fell 6.2% to 124.5 billion won ($95.5 million) amid channel optimization. Aestura’s revenue share rose from 7% to 10% as the group pivots toward global derma-skincare.

Related reading: Can K-beauty retailers crack China a second time?

Luxury’s personalized toolkit for business in China. Join now to sharpen your focus.

Subscribe now

Have an account? Login